Harrow Completes Transfer of the TRIESENCE® New Drug Application
Go back to Harrow Completes Transfer of the TRIESENCE® New Drug Application| (NASDAQ: HROW) | Delayed: 38.87 -0.49 (1.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.36 | 52 Week High | $ | |||
| Open | $39.58 | 52 Week Low | $ | |||
| Day High | $40.90 | P/E | N/A | |||
| Day Low | $38.27 | EPS | $ | |||
| Volume | 516,471 | |||||
